| ISMP (US) | Contact Us | Feedback |
ISMP Canada News
|
|
|
|||||||
|
|||||||||
|
| ||||||||
|
|
|
|||||||
ISMP Canada NewsJune 10, 2021: Health Canada: Ruzurgi (amifampridine) removed from Canadian Market: Options for continued treatment for Lambert-Eaton Myasthenic Syndrome |
|
||||||||
|
|
Copyright © 2000-2016 Institute for Safe Medication Practices Canada (ISMP Canada). All Rights Reserved. | |||||||